Get Access
TreelipClinical Program Risk Radar
Oncology Phase 2Methodology
Sponsor overview

Canadian Cancer Trials Group

Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.

Back to report
Summary

Signal counts

Assets tracked: 1

Watchlist assets: 1

Registry stop assets: 1

Evidence links

Public sources

https://clinicaltrials.gov/study/NCT04093167 | https://clinicaltrials.gov/study/NCT03835819 | https://clinicaltrials.gov/study/NCT04924101 | https://clinicaltrials.gov/study/NCT04118036 | https://clinicaltrials.gov/study/NCT04995016 | https://clinicaltrials.gov/study/NCT05419817 | https://clinicaltrials.gov/study/NCT01905657 | https://clinicaltrials.gov/study/NCT03402880 | https://clinicaltrials.gov/study/NCT06364917 | https://clinicaltrials.gov/study/NCT03752333 | https://clinicaltrials.gov/study/NCT04575961 | https://clinicaltrials.gov/study/NCT04754815 | https://clinicaltrials.gov/study/NCT05467670 | https://clinicaltrials.gov/study/NCT04190056 | https://clinicaltrials.gov/study/NCT06822543 | https://clinicaltrials.gov/study/NCT06305767

Assets

Linked programs